期刊文献+

心脏机械瓣膜置换术后华法林抗凝的调整策略 被引量:4

Strategy of warfarin adjustment after mechanical heart valve replacement
下载PDF
导出
摘要 目的:研究心脏机械瓣膜置换术后华法林抗凝的调整策略及年龄、性别、体重与华法林抗凝剂量、疗效的关系。方法:回顾192例心脏机械瓣膜置换术后服用华法林抗凝患者的临床资料,总结华法林抗凝调整国际标准化比值(INR)的方法,分析年龄、性别、体重和华法林剂量、INR值的关系,观察其抗凝效果及主要不良反应。结果:1例患者因过量服用华法林出现颅内出血死亡,1例过量出现严重皮下出血及鼻出血,1例出现腔隙性脑梗死,2例单用华法林效果不佳,合用拜阿司匹林后INR可调整到目标范围,其余患者效果较好,无严重出血及血栓形成。结论:心脏机械瓣膜置换术后华法林抗凝维持剂量个体差异较大,与年龄、性别、体重无关;抗凝治疗维持INR在1.8-2.5间较为适宜,不增加出血及血栓风险。 Objective:To study the strategy of warfarin anticoagulation and the relationship between age,gender,body weight and the amount,efficacy of warfarin,after mechanical heart valve replacement.Methods:All the 192 patients who had undergone valve replacement in our hospital were involved in this study.Sum the method of warfarin anticoagulation to adjust the international normalized ratio(INR).Analysis the clinical data of age,gender,body weight,warfarin dose and its INR,and observe its anticoagulant effects and major adverse events.Results:One case of death was due to intracranial hemorrhage using overdose of warfarin,1 case of complication was due to excessive subcutaneous bleeding and severe nasal bleeding,1 patient had lacunar brain stem,2 patients were ineffective using of warfarin alone,but after combination with aspirin the INR could adjust to the target range.Rest of the patients had a good result,with no serious bleeding and thrombosis.Conclusion:There was great individual difference in the doses and coagulation effects of warfarin,independent with age,gender and body weight.To maintain INR at 1.8 to 2.5 is appropriate,which does not increase the risk of bleeding and thrombosis.
出处 《临床医药实践》 2010年第4期259-262,共4页 Proceeding of Clinical Medicine
关键词 机械瓣膜置换 华法林 国际标准化比值 mechanical valve replacement warfarin international normalized ratio
  • 相关文献

参考文献9

二级参考文献25

共引文献142

同被引文献33

  • 1孟旭,李金钟,刘岩,张海波.人工机械瓣膜置换术后口服抗凝药的抗凝治疗强度标准[J].中华心血管病杂志,2004,32(7):618-621. 被引量:58
  • 2Malden N J, Santini A, Mather C I, et cd. Minor oral surgery and interferenee with antieoagulation in patients taking warfarin: a retrospective study[ J]. Br J Oral Maxillofae Surg, 2007, 45 (8) : 645 - 647.
  • 3陈纭,黄晓晖,唐海沁,杨维维,朱燕舞,金涌,李俊.RP-HPLC法测定人血清中华法林浓度的方法学研究[J].安徽医药,2007,11(12):1065-1066. 被引量:5
  • 4Li S, Zou Y, Wang X, et al.Warfarin dosage response related pharmacogenetics in Chinese population[J].PLoS One, 2015,10(1) : e0116463.
  • 5Liang R, Li L, Li C, et al.Impact of CYP2C9"3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients[J]. J Thromb Thrombolysis.,2012,34(1): 120-125.
  • 6Kayali MT, Fetieh MW, Abdulsalam MA, et al. Thrombotic Obstruction of Bileaflet Mechanical Prosthetie Heart Valves~ Early Diagnosis and Management [J~. J Cardiovasc Surg (Tori- no), 1998, 39(3): 400-411.
  • 7Butchart EG, Lewis PA, Bethel JA, et al. Adjusting Anticoag- ulation to Prosthesis Thromhogenicity and Patient Risk Factors Recommedations for the Medtronic Hall Valve [J~. Circulation, 1991, 84(5): 61-69.
  • 8Kalaria VG, Passannante MR, Shah T, et al. Effect of Mitral Re- gurgitation on Left Vent ricular Throm bus Formation in DilatedCardiomyopathy ['J]. Am Heart J, 1998, 135(2) ~ 215-220.
  • 9Michael OC. Anticoagulation in the Ambulatory Patien% Basic Principles and Current Concepts in Warfarin Therapy E]~. Top- ics in Geriatric Rehabilitation, 2001, 17(2): 18-37.
  • 10Mackay JW, Fenech ME, Myint KS. Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin I-J]. Br J HospMed(Lond),2012,73(2) : 106-107.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部